ANG Lifesciences India Ltd 31 May 2024 12:00 AM
ANG Lifesciences India reports consolidated net loss of Rs 3.65 crore in the March 2024 quarter,
Net Loss of ANG Lifesciences India reported to Rs 3.65 crore in the quarter ended March 2024 as against net loss of Rs 4.61 crore during the previous quarter ended March 2023. Sales declined 4.06% to Rs 37.84 crore in the quarter ended March 2024 as against Rs 39.44 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 10.14 crore in the year ended March 2024 as against net loss of Rs 0.26 crore during the previous year ended March 2023. Sales declined 33.55% to Rs 146.11 crore in the year ended March 2024 as against Rs 219.89 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales37.8439.44 -4 146.11219.89 -34 OPM %8.88-26.06 -6.616.43 - PBDT-0.29-2.70 89 -0.6011.98 PL PBT-2.34-5.73 59 -8.972.63 PL NP-3.65-4.61 21 -10.14-0.26 -3800 Powered by Capital Market - Live News
ANG Lifesciences India Ltd 29 May 2024 12:00 AM
ANG Lifesciences India to discuss results,
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News
ANG Lifesciences India Ltd 15 Feb 2024 12:00 AM
ANG Lifesciences India reports consolidated net loss of Rs 5.93 crore in the December 2023 quarter,
Net Loss of ANG Lifesciences India reported to Rs 5.93 crore in the quarter ended December 2023 as against net loss of Rs 1.78 crore during the previous quarter ended December 2022. Sales declined 60.47% to Rs 18.55 crore in the quarter ended December 2023 as against Rs 46.93 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales18.5546.93 -60 OPM %-10.305.86 - PBDT-4.45-0.47 -847 PBT-6.37-2.60 -145 NP-5.93-1.78 -233 Powered by Capital Market - Live News
ANG Lifesciences India Ltd 09 Feb 2024 12:00 AM
ANG Lifesciences India schedules board meeting,
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News
ANG Lifesciences India Ltd 15 Nov 2023 12:00 AM
ANG Lifesciences India reports consolidated net loss of Rs 2.32 crore in the September 2023 quarter,
Net loss of ANG Lifesciences India reported to Rs 2.32 crore in the quarter ended September 2023 as against net profit of Rs 2.63 crore during the previous quarter ended September 2022. Sales declined 44.40% to Rs 33.26 crore in the quarter ended September 2023 as against Rs 59.82 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales33.2659.82 -44 OPM %4.9916.13 - PBDT-0.416.50 PL PBT-2.634.39 PL NP-2.322.63 PL Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now